
Mostrar el registro sencillo del ítem
| dc.contributor.author | Bahíllo-Curieses, M Pilar | |
| dc.contributor.author | Prieto Matos, Pablo | |
| dc.contributor.author | Quiroga González, Rocío | |
| dc.contributor.author | Regueras Santos, Laura | |
| dc.contributor.author | Blanco Barrio, Amaya | |
| dc.contributor.author | Rupérez Peña, Sara | |
| dc.contributor.author | Bahíllo-Curieses, M. Pilar | |
| dc.date.accessioned | 2024-02-10T15:58:38Z | |
| dc.date.available | 2024-02-10T15:58:38Z | |
| dc.date.issued | 2016-10-21 | |
| dc.identifier.citation | Bahíllo-Curieses MP, Prieto-Matos P, Quiroga González R, Regueras Santos L, Blanco Barrio A, Rupérez Peña S; Grupo de Endocrinología Pediátrica de Castilla y León. Síndrome de Turner: análisis de 42 casos [Turner syndrome: Study of 42 cases]. Med Clin (Barc). 2016 Oct 21;147(8):348-351 | es_ES |
| dc.identifier.issn | 0025-7753 | |
| dc.identifier.uri | http://hdl.handle.net/10366/155660 | |
| dc.description.abstract | Turner syndrome (TS) is characterized by short stature, gonadal dysgenesis, and total or partial loss of X chromosome. A historical cohorts study of patients with TS≤18 years old followed up in public hospitals in Castilla y Leon was undertaken. Forty-two female patients were included (prenatal diagnosis 11.9%, neonatal diagnosis 14.3%) with current median age 11.9±4.2 years. Short stature was the reason for consultation in 87.1%. Total monosomy of X chromosome was present in 40.5%. The most frequently associated comorbidity was opthalmological (50%), with heart defects in 23.8%. Ninety-three percent were treated with growth hormone (GH), mean age at the beginning of treatment was 7.43±3.4 years and mean height standard deviation was -2.84±1.08. Final height was reached in 10 patients only (mean final height 151.47±6.09cm). Chronological age of puberty induction was 13.2±0.94 years (bone age 12.47±1.17 years). Short stature was an important clinical sign for the diagnosis of TS, accompanied in some cases by other findings, with good response to GH treatment. | es_ES |
| dc.language.iso | spa | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | Prognosis | * |
| dc.subject.mesh | Growth Hormone | * |
| dc.subject.mesh | Follow-Up Studies | * |
| dc.subject.mesh | Humans | * |
| dc.subject.mesh | Adolescent | * |
| dc.subject.mesh | Turner Syndrome | * |
| dc.subject.mesh | Infant | * |
| dc.subject.mesh | Retrospective Studies | * |
| dc.title | Turner syndrome: Study of 42 cases | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.identifier.doi | 10.1016/j.medcli.2016.06.033 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.pmid | 27575526 | |
| dc.identifier.essn | 1578-8989 | |
| dc.journal.title | Medicina Clínica | es_ES |
| dc.volume.number | 147 | es_ES |
| dc.issue.number | 8 | es_ES |
| dc.page.initial | 348 | es_ES |
| dc.page.final | 351 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | pronóstico | * |
| dc.subject.decs | humanos | * |
| dc.subject.decs | lactante | * |
| dc.subject.decs | estudios de seguimiento | * |
| dc.subject.decs | estudios retrospectivos | * |
| dc.subject.decs | adolescente | * |
| dc.subject.decs | síndrome de Turner | * |
| dc.subject.decs | hormona del crecimiento | * |








